Mai Pho to United States
This is a "connection" page, showing publications Mai Pho has written about United States.
Connection Strength
0.591
-
Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs. Med Care. 2025 Feb 01; 63(2):77-88.
Score: 0.088
-
How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States. Int J Drug Policy. 2023 02; 112:103930.
Score: 0.077
-
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis. Addict Sci Clin Pract. 2022 04 25; 17(1):24.
Score: 0.073
-
Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19. Obesity (Silver Spring). 2020 10; 28(10):1806-1810.
Score: 0.065
-
Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose. JAMA Netw Open. 2019 05 03; 2(5):e193209.
Score: 0.060
-
Benzodiazepines and Opioid co-use Among Rural People Who Use Drugs: Findings From the Rural Opioid Initiative. Subst Use Addctn J. 2025 Oct; 46(4):847-858.
Score: 0.023
-
Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S. J Subst Use Addict Treat. 2025 Apr; 171:209629.
Score: 0.022
-
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
Score: 0.022
-
Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid Initiative. Drug Alcohol Depend. 2025 Jan 01; 266:112498.
Score: 0.022
-
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative. Harm Reduct J. 2024 Aug 24; 21(1):154.
Score: 0.022
-
Barriers to Healthcare and Social Service Utilization Among Rural Older Adults Who Use Drugs. J Appl Gerontol. 2024 12; 43(12):1977-1984.
Score: 0.021
-
Opioid use, prescribing and fatal overdose patterns among racial/ethnic minorities in the United States: A scoping review and conceptual risk environment model. Drug Alcohol Rev. 2024 Jul; 43(5):1143-1159.
Score: 0.021
-
Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. Int J Drug Policy. 2025 Jul; 141:104222.
Score: 0.020
-
COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities. J Rural Health. 2021 01; 37(1):172-174.
Score: 0.016
-
Multicenter Outbreak of Gram-Negative Bloodstream Infections in Hemodialysis Patients. Am J Kidney Dis. 2019 11; 74(5):610-619.
Score: 0.015
-
Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459.
Score: 0.013
-
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 05; 162(9):619-29.
Score: 0.011